Intraoperative handling and wound healing: Controlled clinical trial comparing coated Vicryl® plus antibacterial suture (coated polyglactin 910 suture with triclosan) with coated Vicryl® suture (coated polyglactin 910 suture)

Surgical Infections

Volumn 6, Issue 3, 2005, Pages 313-321

  Ford, Henri R ^a   Jones, Peter ^b   Gaines, Barbara ^c   Reblock, Kimberly ^c   Simpkins, Dorella L ^d  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b With Confidence Ltd   (United Kingdom)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d ETHICON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; POLYGLACTIN; SUTURE MATERIAL; TRICLOSAN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EDEMA; ERYTHEMA; FEMALE; GENERAL SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PAIN ASSESSMENT; PEDIATRICS; PEROPERATIVE CARE; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEROMA; SKIN TEMPERATURE; SURGICAL INFECTION; SUTURING METHOD; WOUND HEALING; WOUND INFECTION;

ADOLESCENT; ANTI-INFECTIVE AGENTS, LOCAL; CHILD; CHILD, PRESCHOOL; COATED MATERIALS, BIOCOMPATIBLE; HUMANS; INFANT; POLYGLACTIN 910; PROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; SUTURES; TREATMENT OUTCOME; TRICLOSAN; WOUND HEALING;

EID: 27844443479     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2005.6.313     Document Type: Article

References (19)

1. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol 1999;20:247-278.
2. Fry DE. The economic costs of surgical site infection. Surg Infect 2002;3(Suppl 1):S37-S43.
3. CDC: Nosocomial infection update. Emerg Infectious Diseases 1998;4:(3).
4. Rothenburger S, Spangler D, Bhende S, et al. In vitro antibacterial evaluation of coated Vicryl* Plus antibacterial suture (coated polyglactin 910 with triclosan) using zone of inhibition assays. Surg Infect 2002;3(Suppl 1):S79-S87.
5. Storch M, Scalzo H, Jacinto G. Physical and functional comparison of coated Vicryl* Plus antibacterial suture (coated polyglactin 910 with triclosan) with coated Vicryl* suture (coated polyglactin 910). Surg Infect 2002;3(Suppl 1):S65-S77.
6. Storch M, Perry LC, Davidson JM, et al. A 28-day study of the effect of coated Vicryl* Plus antibacterial suture (coated polyglactin 910 with triclosan) on wound healing in guinea pig linear incisional skin wounds. Surg Infect 2002;3(Suppl 1):S89-S98.
7. Gilbert P, McBain AJ. Literature-based evaluation of the potential risks associated with impregnation of medical devices and implants with triclosan. Surg Infect 2002;3(Suppl 1):S55-S63.
8. Storch ML, Rothenburger SJ, Jacinto G. Experimental efficacy of coated Vicryl* Plus antibacterial suture in guinea pigs challenged with Staphylococcus aureus. Surgical Infections 2004; 5:281-288.
9. Barbolt TA. Chemistry and safety of triclosan and its use as an antibacterial coating on coated VICRYL* Plus antibacterial suture (coated polyglactin 910 with triclosan). Surg Infect 2002;3(Suppl 1):S45-S54.
10. Merkel SI, Shayevitz JR, Voepel-Lewis T, Malviya S. The FLACC: A behavioral scale for scoring postoperative pain in young children. Pediatr Nurs 1977:23: 293-297.
11. Bamber AI, Neal TJ. An assessment of triclosan susceptibility in methicillin-resistant and methicillin-sensitive Staphylococcus aureus. J Hosp Infect 1988;41:107-109.
12. Zafar AB, Butler RC, Reese DJ, et al. Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 1995;23:200-208.
13. Webster J, Faoagali JL, Cartwright D. Elimination of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan. J Paediatr Child Health 1994;30:59-64.
14. Jones CL, Ritchie JA, Marsh PD, et al. The effect of long-term use of a dentifrice containing zinc citrate and a non-ionic agent on the oral flora. J Dent Res 1988;67:46-50.
15. Jones RD, Jampani HB, Newman JL, et al. Triclosan: A review of effectiveness and safety in health care settings. Am J Infect Control 2000;28:184-196.
16. Chu CC. Classification and general characteristics of suture materials. In Chu CC, von Fraunhofer JA, Greisler HP, eds. Wound Closure Biomaterials and Devices. New York: CRC Press, 1997:39-64.
17. Poole GV, Meredith JW, Kon ND, et al. Suture technique and wound-bursting strength. Am Surg 1984;50:569-572.
18. Rappaport W, Allen R, Chvapil M, et al. A comparison of parallel versus perpendicular placement of retention sutures in abdominal wound closure. Am Surg 1990;56:618-623.
19. Charles D, Williams K, Perry LC, et al. An improved method of in vivo wound disruption and measurement. J Surg Res 1992;52:214-218.